Cann Global Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cann Global Ltd with three other companies in this sector in AUSTRALIA : Regeneus Ltd (2020 sales of 1.66 million Australian Dollars [US$1.28 million] ), Recce Pharmaceuticals Ltd (1.15 million Australian Dollars [US$884,757.11 ] of which 100% was RESEARCH AND DEVVELOPMENT OF PHARMACEUTI), and MGC Pharmaceuticals Ltd (2.09 million Australian Dollars [US$1.61 million] of which 100% was Supply of medicinal cannabis products).

Sales Analysis. Sales increased substantially in 2020: During the year ended June of 2020, sales at Cann Global Ltd were A$1.93 million (US$1.49 million). This is an increase of 219.5% versus 2019, when the company's sales were A$603,932.00 . Despite this increase, sales are still well below the level achieved in 2018, when Cann Global Ltd reported sales of A$3.87 million.